Matches in Wikidata for { <http://www.wikidata.org/entity/Q66075853> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q66075853 description "assaig clínic" @default.
- Q66075853 description "clinical trial" @default.
- Q66075853 description "clinical trial" @default.
- Q66075853 description "clinical trial" @default.
- Q66075853 description "clinical trial" @default.
- Q66075853 description "ensaio clínico" @default.
- Q66075853 description "ensayo clínico" @default.
- Q66075853 description "ensayu clínicu" @default.
- Q66075853 description "essai clinique" @default.
- Q66075853 description "klinisch onderzoek" @default.
- Q66075853 description "клінічне випробування" @default.
- Q66075853 description "կլինիկական փորձարկում" @default.
- Q66075853 name "The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum" @default.
- Q66075853 name "The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide" @default.
- Q66075853 type Item @default.
- Q66075853 label "The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum" @default.
- Q66075853 label "The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide" @default.
- Q66075853 prefLabel "The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum" @default.
- Q66075853 prefLabel "The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide" @default.
- Q66075853 P1050 Q66075853-E5C96DAC-B4BA-421F-9216-26C9A6E07683 @default.
- Q66075853 P1132 Q66075853-0FA7DF87-CAD3-4D77-B9B9-74FB4F7D5A3D @default.
- Q66075853 P1476 Q66075853-305737F7-F09A-431A-936F-DF83954E2975 @default.
- Q66075853 P17 Q66075853-A1F10E52-408C-4D83-998B-252357073D19 @default.
- Q66075853 P2899 Q66075853-60B2A0CB-DB36-465E-A871-6329B70D7170 @default.
- Q66075853 P3098 Q66075853-ADB702E5-A2C4-4FD5-ADCA-99674EE9C5B0 @default.
- Q66075853 P31 Q66075853-92FEBC8C-92EB-416F-8F0C-6AA94D5C23B2 @default.
- Q66075853 P580 Q66075853-666A8E35-E3BC-4EF8-9FED-E8E55C4C639C @default.
- Q66075853 P582 Q66075853-A75273ED-C142-4FBB-BBB2-BB2EB44AB7FA @default.
- Q66075853 P6099 Q66075853-85FE906B-81D5-4357-995C-4173C70BFB24 @default.
- Q66075853 P8363 Q66075853-0ECB3114-25CE-4F0B-BA14-7CBCA634F80B @default.
- Q66075853 P1050 Q239027 @default.
- Q66075853 P1132 "+40" @default.
- Q66075853 P1476 "The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum" @default.
- Q66075853 P17 Q40 @default.
- Q66075853 P2899 "+18" @default.
- Q66075853 P3098 "NCT03010072" @default.
- Q66075853 P31 Q30612 @default.
- Q66075853 P580 "2017-06-09T00:00:00Z" @default.
- Q66075853 P582 "2018-12-31T00:00:00Z" @default.
- Q66075853 P6099 Q42824440 @default.
- Q66075853 P8363 Q78089383 @default.